Mesenteric veins
Extension here raises concern for intestinal congestion and ischemia.
GI
Budd-Chiari Syndrome and Portal Vein Thrombosis
First decide whether blood cannot enter the liver or cannot leave it.
- Distinguish hepatic venous outflow obstruction from portal venous inflow obstruction.
- Recognize acute and chronic clinical and imaging patterns.
- Choose anticoagulation, decompression, and transplant principles from disease severity.
Mass workup
Characterize before sampling
The figure separates morphology, enhancement, spread, and the decision to obtain tissue.
Quick check
A 34-year-old woman with polycythemia vera develops abdominal pain, tender hepatomegaly, and rapidly accumulating ascites. Doppler ultrasound shows absent flow in the hepatic veins.
Which vascular lesion best explains this presentation?
Reason it through
- What is the hemodynamic direction of the block?Blood cannot exit the liver through the hepatic veins.
- Why is the liver enlarged and painful?Sinusoidal congestion stretches the hepatic capsule.
- What clue selects the syndrome?The Doppler abnormality is in hepatic venous outflow.
Risk factors are not interchangeable
Systemic thrombophilia matters in both disorders, but local portal factors shift the prior probability.
Myeloproliferative neoplasms are high-yield causes of splanchnic thrombosis and should remain visible even when blood counts are distorted by portal hypertension.
Cirrhosis, abdominal malignancy, pancreatitis, infection, surgery, and inherited or acquired thrombophilia can predispose to portal vein thrombosis.
Select the strongest association with hepatic venous outflow thrombosis.
Choose the first item.
Outflow block versus inflow block
The vessel named on imaging predicts the pressure pattern.
Budd-Chiari syndrome is obstruction of hepatic venous outflow, usually from hepatic vein thrombosis and sometimes from the adjacent inferior vena cava.
Portal vein thrombosis blocks portal inflow; acute extension into mesenteric veins can threaten bowel, while chronic disease can form cavernous collaterals.
Compare the two vascular territories.
Outflow obstruction causes sinusoidal congestion, tender hepatomegaly, ascites, and liver dysfunction.
Inflow obstruction causes portal hypertension; acute disease may cause abdominal pain and intestinal ischemia.
Both may present with abdominal pain and portal-hypertensive complications and require thrombosis-risk evaluation.
Name the blocked vessel before naming the syndrome.
Read the scan as a flow diagram
Localize the obstruction from gut to liver to vena cava.
Portal blood enters at the porta hepatis, crosses sinusoids, drains through hepatic veins, and reaches the inferior vena cava.
Cavernous transformation describes serpiginous periportal collateral channels that develop around chronic portal vein obstruction.
Place each finding on the vascular route.
Main portal vein
Thrombus here blocks inflow and may lead to cavernous transformation.
Hepatic sinusoids
Outflow obstruction raises sinusoidal pressure and produces congestion.
Hepatic veins and adjacent vena cava
Occlusion here defines the Budd-Chiari outflow territory.
Let tempo change the danger
The same thrombus location has different consequences as extension and organ dysfunction increase.
Acute portal-mesenteric extension carries greater immediate intestinal risk than stable chronic cavernous transformation.
Progressive liver failure despite anticoagulation and decompression moves Budd-Chiari syndrome toward transplant evaluation.
Rank the scenarios by urgency.
Higher immediate threat
Higher immediate threat
Higher immediate threat
Higher immediate threat
Move from suspicion to vascular map
Confirm flow direction and define thrombus extent before selecting therapy.
Doppler ultrasound is usually the first vascular study.
Contrast CT or MRI clarifies hepatic vein, portal vein, inferior vena cava, and mesenteric extension and also assesses liver morphology and complications.
Order the diagnostic sequence.
Pair pain, ascites, hepatomegaly, portal hypertension, or bowel symptoms with the tempo of illness.
Assess patency, direction, velocity, and collateral flow in hepatic and portal veins.
Define thrombus location, chronicity clues, parenchymal effects, and mesenteric extension.
Evaluate myeloproliferative disease, thrombophilia, malignancy, cirrhosis, inflammation, and local provoking factors.
Assess liver failure, variceal bleeding, ascites, and intestinal ischemia.
Treatment escalates with physiology
Anticoagulation addresses thrombosis, but persistent congestion or organ failure requires more.
Unless contraindicated, anticoagulation is central for Budd-Chiari syndrome and recent noncirrhotic portal vein thrombosis, with duration shaped by reversibility and ongoing thrombophilia.
In cirrhosis, recent limited thrombosis can be observed with imaging every 3 months, whereas recent more than 50 percent occlusion or main portal or mesenteric involvement favors anticoagulation; chronic complete cavernous transformation is not routinely anticoagulated.
Budd-Chiari management can progress from anticoagulation and treatment of complications to angioplasty or stenting, TIPS, and liver transplantation.
Reveal the next step at each severity level.
Begin therapeutic anticoagulation and treat the underlying prothrombotic condition.
These clots have a strong recanalization or propagation-prevention rationale.
Observe with repeat cross-sectional imaging every 3 months when there is no ischemia and occlusion is less than 50 percent.
Progression changes the treatment branch.
Consider anticoagulation when occlusion exceeds 50 percent or involves the main portal or mesenteric veins.
Transplant candidacy, progression, and multiple vascular beds increase the benefit of recanalization.
Do not routinely anticoagulate complete occlusion with established collateralization.
Manage portal-hypertensive complications and individual transplant goals instead.
Use angioplasty for suitable focal stenosis, TIPS for decompression, and transplant for progressive failure.
Escalation follows anatomy and hepatic response.
Workup gate
Choose the next characterization step
Identify what is still unknown before ordering another test or biopsy.
Which vascular lesion best explains this presentation?
- Key finding. A 34-year-old woman with polycythemia vera develops abdominal pain, tender hepatomegaly, and rapidly accumulating ascites. Doppler ultrasound shows absent flow in the hepatic veins.
- Answer. Hepatic venous outflow thrombosis
- Why. The classic triad plus absent hepatic venous flow identifies Budd-Chiari syndrome.
- Board rule. Pain plus hepatomegaly plus ascites is the Budd-Chiari alarm pattern.
Stage 1 of 3: Overview
Overview
Budd-Chiari Syndrome and Portal Vein Thrombosis
Confirm flow direction and define thrombus extent before selecting therapy.
Plan the diagnostic workup
Five patients force localization before treatment.
Cross out tests that answer the wrong question and highlight what remains unknown. Each case practices the order of workup.
A 29-year-old woman taking estrogen-containing contraception has abdominal pain, ascites, and tender hepatomegaly. Doppler shows thrombosed hepatic veins.
What is the best initial disease-directed therapy if she has no contraindication?
Reason it through
- Which compartment is obstructed?The hepatic venous outflow tract.
- What process must be stopped first?Propagation of venous thrombosis.
- What happens if congestion persists?Escalate to recanalization or TIPS based on anatomy and severity.
Which compartment is obstructed?What process must be stopped first?
- Which compartment is obstructed?The hepatic venous outflow tract.
- What process must be stopped first?Propagation of venous thrombosis.
- What happens if congestion persists?Escalate to recanalization or TIPS based on anatomy and severity.
A 63-year-old man with cirrhosis has chronic portal vein thrombosis and serpiginous vessels at the porta hepatis. He has splenomegaly but no acute abdominal tenderness.
What does the periportal vascular network represent?
Reason it through
- What does serpiginous imply here?Multiple collateral vascular channels.
- Why are they at the porta?They bypass chronic portal vein obstruction.
- Does this prove acute ischemia?No; it is a marker of chronicity.
What does serpiginous imply here?Why are they at the porta?
- What does serpiginous imply here?Multiple collateral vascular channels.
- Why are they at the porta?They bypass chronic portal vein obstruction.
- Does this prove acute ischemia?No; it is a marker of chronicity.
A 48-year-old patient with recent portal vein thrombosis develops worsening pain, guarding, and lactate elevation. CT shows thrombus extending into the superior mesenteric vein.
Which complication is most urgent?
Reason it through
- What new territory is involved?The superior mesenteric venous drainage.
- What does guarding signal?Possible infarction with peritoneal inflammation.
- How should tempo change management?Trigger urgent multidisciplinary escalation.
What new territory is involved?What does guarding signal?
- What new territory is involved?The superior mesenteric venous drainage.
- What does guarding signal?Possible infarction with peritoneal inflammation.
- How should tempo change management?Trigger urgent multidisciplinary escalation.
A 37-year-old man with Budd-Chiari syndrome remains ascitic with worsening liver tests despite anticoagulation. No short focal stenosis is suitable for angioplasty.
What intervention best decompresses the liver?
Reason it through
- Why did anticoagulation not finish the job?Established outflow obstruction still causes sinusoidal hypertension.
- Can a focal lesion be opened?No suitable stenosis is present.
- What creates an alternate drainage route?TIPS.
Why did anticoagulation not finish the job?Can a focal lesion be opened?
- Why did anticoagulation not finish the job?Established outflow obstruction still causes sinusoidal hypertension.
- Can a focal lesion be opened?No suitable stenosis is present.
- What creates an alternate drainage route?TIPS.
A patient with Budd-Chiari syndrome develops progressive hepatic failure despite anticoagulation and a technically patent TIPS.
What is the definitive next principle?
Reason it through
- Was thrombosis treated?Yes, anticoagulation was given.
- Was congestion decompressed?Yes, the TIPS is patent.
- What remains irreversible?Progressive hepatic failure requiring transplant evaluation.
Was thrombosis treated?Was congestion decompressed?
- Was thrombosis treated?Yes, anticoagulation was given.
- Was congestion decompressed?Yes, the TIPS is patent.
- What remains irreversible?Progressive hepatic failure requiring transplant evaluation.
Rapid review
Three questions to check
Which vascular lesion best explains this presentation?
Hepatic venous outflow thrombosis. The classic triad plus absent hepatic venous flow identifies Budd-Chiari syndrome.
Which compartment is obstructed?
The hepatic venous outflow tract.
What process must be stopped first?
Propagation of venous thrombosis.
Medically reviewed
Fatima Ali, DO
PGY-1 Resident Physician in Psychiatry
University Hospitals, Columbia
DO from Kansas City University
Resident physician and founding medical reviewer at Bone Wizardry, focused on clinical accuracy, clear diagnostic reasoning, and practical board-oriented teaching across the curriculum.
Languages: English, Urdu
Primary reviewerFull physician profile
Medically reviewed
Sources
- Budd-Chiari Syndrome2025
- Portal Vein Thrombosis2024
- AGA Clinical Practice Update on Management of Portal Vein Thrombosis in Patients With Cirrhosis: Expert Review2025
Bone Wizardry is a study resource for medical students. It is not medical advice.